289 related articles for article (PubMed ID: 36389678)
21. Comprehensive analysis of m
Zhao K; Li W; Yang Y; Hu X; Dai Y; Huang M; Luo J; Zhang K; Zhao N
Front Immunol; 2022; 13():955848. PubMed ID: 36203569
[TBL] [Abstract][Full Text] [Related]
22. Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis.
Zhu M; Zeng Q; Fan T; Lei Y; Wang F; Zheng S; Wang X; Zeng H; Tan F; Sun N; Xue Q; He J
Front Immunol; 2022; 13():783495. PubMed ID: 35222371
[TBL] [Abstract][Full Text] [Related]
23. Contributions and Prognostic Values of N6-Methyladenosine RNA Methylation Regulators in Hepatocellular Carcinoma.
Qi LW; Jia JH; Jiang CH; Hu JM
Front Genet; 2020; 11():614566. PubMed ID: 33519919
[TBL] [Abstract][Full Text] [Related]
24. Differential analysis of RNA methylation regulators in gastric cancer based on TCGA data set and construction of a prognostic model.
Li J; Zuo Z; Lai S; Zheng Z; Liu B; Wei Y; Han T
J Gastrointest Oncol; 2021 Aug; 12(4):1384-1397. PubMed ID: 34532096
[TBL] [Abstract][Full Text] [Related]
25. Construction and validation of prognostic prediction established on N6-methyladenosine related genes in cervical squamous cell carcinoma.
Chen D; Guo W; Yu H; Yang J
Transl Cancer Res; 2022 Sep; 11(9):3064-3079. PubMed ID: 36237271
[TBL] [Abstract][Full Text] [Related]
26. Identification of m6A methyltransferase-related genes predicts prognosis and immune infiltrates in head and neck squamous cell carcinoma.
Zhang Y; Li L; Ye Z; Zhang L; Yao N; Gai L
Ann Transl Med; 2021 Oct; 9(20):1554. PubMed ID: 34790760
[TBL] [Abstract][Full Text] [Related]
27. Investigating the clinical role and prognostic value of genes related to insulin-like growth factor signaling pathway in thyroid cancer.
Liu J; Miao X; Yao J; Wan Z; Yang X; Tian W
Aging (Albany NY); 2024 Feb; 16(3):2934-2952. PubMed ID: 38329437
[TBL] [Abstract][Full Text] [Related]
28. m6A RNA methylation regulators play an important role in the prognosis of patients with testicular germ cell tumor.
Cong R; Ji C; Zhang J; Zhang Q; Zhou X; Yao L; Luan J; Meng X; Song N
Transl Androl Urol; 2021 Feb; 10(2):662-679. PubMed ID: 33718069
[TBL] [Abstract][Full Text] [Related]
29. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma.
Deng ZL; Zhou DZ; Cao SJ; Li Q; Zhang JF; Xie H
Inflammation; 2022 Aug; 45(4):1732-1751. PubMed ID: 35322324
[TBL] [Abstract][Full Text] [Related]
30. Tumor Expression Profile Analysis Developed and Validated a Prognostic Model Based on Immune-Related Genes in Bladder Cancer.
Dong B; Liang J; Li D; Song W; Zhao S; Ma Y; Song J; Zhu M; Yang T
Front Genet; 2021; 12():696912. PubMed ID: 34512722
[No Abstract] [Full Text] [Related]
31. Expression of pyroptosis-associated genes and construction of prognostic model for thyroid cancer.
Guo L; Yuan M; Jiang S; Jin G; Li P
Transl Cancer Res; 2023 Dec; 12(12):3360-3383. PubMed ID: 38193001
[TBL] [Abstract][Full Text] [Related]
32. Characterization of m6A methylation modifications and tumor microenvironment infiltration in thyroid cancer.
Ji FH; Yang Z; Sun C; Lowe S; Qiu XG
Clin Transl Oncol; 2023 Jan; 25(1):269-282. PubMed ID: 36163443
[TBL] [Abstract][Full Text] [Related]
33. Estimating the prognosis of esophageal squamous cell carcinoma based on The Cancer Genome Atlas (TCGA) of m6A methylation-associated genes.
Pu Y; Lu X; Yang X; Yang Y; Wang D; Li M; Guan W; Xu M
J Gastrointest Oncol; 2022 Feb; 13(1):1-12. PubMed ID: 35284129
[TBL] [Abstract][Full Text] [Related]
34. An immune-related exosome signature predicts the prognosis and immunotherapy response in ovarian cancer.
Zhu K; Ma J; Tian Y; Liu Q; Zhang J
BMC Womens Health; 2024 Jan; 24(1):49. PubMed ID: 38238671
[TBL] [Abstract][Full Text] [Related]
35. A signature of immune-related gene pairs (IRGPs) for risk stratification and prognosis of oral cancer patients.
Yu Y; Tian J; Hou Y; Zhang X; Li L; Cong P; Ji L; Wang X
World J Surg Oncol; 2022 Jul; 20(1):227. PubMed ID: 35804390
[TBL] [Abstract][Full Text] [Related]
36. N6-methyladenosine Modification-Related Long Non-Coding RNAs are Potential Biomarkers for Predicting the Prognosis of Patients With Osteosarcoma.
Yang K; Wang F; Li K; Peng G; Yang H; Xu H; Xiang Y; Sun H
Technol Cancer Res Treat; 2022; 21():15330338221085354. PubMed ID: 35422168
[No Abstract] [Full Text] [Related]
37. 5-methylcytosine RNA methylation regulators affect prognosis and tumor microenvironment in lung adenocarcinoma.
Liu T; Hu X; Lin C; Shi X; He Y; Zhang J; Cai K
Ann Transl Med; 2022 Mar; 10(5):259. PubMed ID: 35402591
[TBL] [Abstract][Full Text] [Related]
38. m
Hou J; Shan H; Zhang Y; Fan Y; Wu B
Am J Otolaryngol; 2020; 41(4):102547. PubMed ID: 32474328
[TBL] [Abstract][Full Text] [Related]
39. YTHDF3as a prognostic predictive biomarker of thyroid cancer and its correlation with immune infiltration.
Zhang Y; Chen Y; Chen R; Zhou H; Lin Y; Li B; Song H; Zhou G; Dong M; Xu H
BMC Cancer; 2023 Sep; 23(1):882. PubMed ID: 37726690
[TBL] [Abstract][Full Text] [Related]
40. Integrated analysis on the N6-methyladenosine-related long noncoding RNAs prognostic signature, immune checkpoints, and immune cell infiltration in clear cell renal cell carcinoma.
Qiu Y; Wang X; Fan Z; Zhan S; Jiang X; Huang J
Immun Inflamm Dis; 2021 Dec; 9(4):1596-1612. PubMed ID: 34432955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
